TrialBMC pediatrics2024

Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?

Büşra Tetik Dinçer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.